Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: Application to a bioavailability study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 2, 2009, Pages 189-193

  Yang, Ding ^a   Yu, Chen ^b   Li, Shuijun ^a,b   Liu, Gangyi ^b   Lu, Youli ^a   Wang, Yiping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI XUHUI CENTRAL HOSPITAL   (China)

Author keywords

Bioavailability study; Changrolin; LC MS MS; Pharmacokinetics; Rat plasma

Indexed keywords

CHANGROLIN; TIAPRIDE;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CHROMATOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG STABILITY; ELECTROSPRAY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL AVAILABILITY; CALIBRATION; CHROMATOGRAPHY, LIQUID; QUINAZOLINES; RATS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 66049124793     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.04.010     Document Type: Article

References (18)

1. Liu C.X., Gu Y.B., Feng J.L., Wei G.L., Xiao S.H., and Sun J.L. Yao Xue Xue Bao 31 (1996) 666-670
2. Lu L.L. Zhongguo Yao Li Xue Bao 20 (1999) 1015-1018
3. Lu L.L., Habuchi Y., Tanaka H., and Morikawa J. Clin. Exp. Pharmacol. Physiol. 22 (1995) 337-341
4. Wu Y.J., and Fang D.C. Zhongguo Yao Li Xue Bao 12 (1991) 363-367
5. Kuang Y., and Liu T.P. Zhongguo Yao Li Xue Bao 11 (1990) 225-229
6. Pan H., Shen W.Q., Yu Z.M., and Xu B. Zhongguo Yao Li Xue Bao 11 (1990) 317-321
7. Chen W.Z., Wang C.G., Yang X.Y., Cai N.S., and Zhu J.R. Yao Xue Xue Bao 20 (1985) 505-508
8. Shen Y.T., Xu N.S., Gu S.L., and Wu P.M. Zhongguo Yao Li Xue Bao 4 (1983) 251-253
9. Xu J.M., Yin X.L., Chen Y.M., Qi H.M., Li C.F., Shen L.Y., Chen W.Z., and Wang C.G. Zhongguo Yao Li Xue Bao 8 (1987) 227-231
10. Nattel S., and Carlsson L. Nat. Rev. Drug Discov. 5 (2006) 1034-1049
11. Takada M., Goto T., Kotake T., Saito M., Kawato N., Nakai M., Gunji T., and Shibakawa M. J. Clin. Pharm. Ther. 30 (2005) 5-12
12. Campbell T.J., and Williams K.M. Br. J. Clin. Pharmacol. 52 (2001) 21S-34S
13. Qu Z.X., Cao C.Y., and Zhuang Y.H. Yao Xue Xue Bao 15 (1980) 449-455
14. Velazquez A.M., Martinez L., Abrego V., Balboa M.A., Torres L.A., Camacho B., Diaz-Barriga S., Romero A., Lopez-Castanares R., and Angeles E. Eur. J. Med. Chem. 43 (2008) 486-500
15. Li Y., Yang Z.S., Zhang H., Cao B.J., Wang F.D., Zhang Y., Shi Y.L., Yang J.D., and Wu B.A. Bioorg. Med. Chem. 11 (2003) 4363-4368
16. D.L. Bai, W.Z. Chen, Y.X. Bu, Y.P. Wang, Y.L. Dong, A.L. Kang, N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof, US Patent 6605635B1, 08/12/2003.
17. Dai D.Z., Rong P., Huang J., Liu J., Cheng J.H., Chen Y.H., Qiu Y.T., Huang W.L., and Peng S.X. Zhongguo Yao Li Xue Bao 12 (1991) 411-415
18. Shou W.Z., and Naidong W. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825 (2005) 186-192